[go: up one dir, main page]

MX9703839A - Soluciones intravenosas de lubeluzol. - Google Patents

Soluciones intravenosas de lubeluzol.

Info

Publication number
MX9703839A
MX9703839A MX9703839A MX9703839A MX9703839A MX 9703839 A MX9703839 A MX 9703839A MX 9703839 A MX9703839 A MX 9703839A MX 9703839 A MX9703839 A MX 9703839A MX 9703839 A MX9703839 A MX 9703839A
Authority
MX
Mexico
Prior art keywords
lubeluzole
intravenous solutions
solution
intravenous
lubelozole
Prior art date
Application number
MX9703839A
Other languages
English (en)
Other versions
MXPA97003839A (es
Inventor
Marc Karel Josef Francois
Josef Peeters
Christiane Gabriella Gerardus
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MXPA97003839A publication Critical patent/MXPA97003839A/es
Publication of MX9703839A publication Critical patent/MX9703839A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe una solucion para administracion intravenosa que contiene lubelozol o una sal de adicion farmacéuticamente aceptable del mismo, un agente isotonizador, agua y substancias ácidas y básicas para ajustar el pH de la solucion en la escala de 2.5 a 3.6; así como procedimientos para preparar la misma.
MX9703839A 1994-11-24 1995-11-16 Soluciones intravenosas de lubeluzol. MX9703839A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203422.4 1994-11-24
EP94203422 1994-11-24
PCT/EP1995/004520 WO1996015790A1 (en) 1994-11-24 1995-11-16 Lubeluzole intravenous solutions

Publications (2)

Publication Number Publication Date
MXPA97003839A MXPA97003839A (es) 1997-08-01
MX9703839A true MX9703839A (es) 1997-08-30

Family

ID=8217408

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703839A MX9703839A (es) 1994-11-24 1995-11-16 Soluciones intravenosas de lubeluzol.

Country Status (19)

Country Link
US (1) US5744484A (es)
EP (1) EP0794777A1 (es)
JP (1) JPH10509712A (es)
CN (1) CN1166787A (es)
AR (1) AR002001A1 (es)
AU (1) AU693969B2 (es)
BR (1) BR9509821A (es)
CA (1) CA2205606A1 (es)
CZ (1) CZ155897A3 (es)
FI (1) FI972204A7 (es)
HU (1) HUT77390A (es)
IL (1) IL116102A (es)
MX (1) MX9703839A (es)
NO (1) NO972303D0 (es)
PL (1) PL320296A1 (es)
SK (1) SK65197A3 (es)
TR (1) TR199501482A1 (es)
WO (1) WO1996015790A1 (es)
ZA (1) ZA959995B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AU7298196A (en) * 1995-10-25 1997-05-15 Janssen Pharmaceutica N.V. Infusions of neuroprotectants and perfluorochemicals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US5010198A (en) * 1984-12-03 1991-04-23 Janssen Pharmaceutica N.V. Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
FI972204L (fi) 1997-05-23
AR002001A1 (es) 1998-01-07
US5744484A (en) 1998-04-28
PL320296A1 (en) 1997-09-15
IL116102A (en) 2000-02-29
HUT77390A (hu) 1998-04-28
BR9509821A (pt) 1997-10-21
SK65197A3 (en) 1997-12-10
FI972204A0 (fi) 1997-05-23
TR199501482A1 (tr) 1996-10-21
CN1166787A (zh) 1997-12-03
IL116102A0 (en) 1996-01-31
NO972303L (no) 1997-05-21
CA2205606A1 (en) 1996-05-30
WO1996015790A1 (en) 1996-05-30
ZA959995B (en) 1997-05-23
EP0794777A1 (en) 1997-09-17
FI972204A7 (fi) 1997-05-23
JPH10509712A (ja) 1998-09-22
NO972303D0 (no) 1997-05-21
CZ155897A3 (en) 1997-10-15
AU693969B2 (en) 1998-07-09
AU4172996A (en) 1996-06-17

Similar Documents

Publication Publication Date Title
AR011846A1 (es) Una composicion farmaceutica, y el procedimiento para prepararla
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
CO5190689A1 (es) Sales de tramadol formadas por tramadol y un edulcorante y formas farmaceuticas que contienen dichas sales
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
AR002932A1 (es) Solucion acuosa de interferon
ES2145264T3 (es) (2,4-disulfofenil)-n-tert-butilnitrona, sus sales y su utilizacion como agentes captadores de radicales farmaceuticos.
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
YU54499A (sh) Farmaceutski preparat za primenu na mukozu
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
YU69096A (sh) Vodeni farmaceutski rastvor
ES2192256T3 (es) Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas.
BR9916114A (pt) Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
IT1260638B (it) Sistema per la preparazione di un fluido da utilizzare in trattamenti medicali
SE8500996D0 (sv) Method of treatment
ES8107021A1 (es) Un procedimiento para preparar una solucion oftalmica que contiene una sal de 2-acetil-7-(2-hidroxi-3-isopropilamino- propoxi) benzofurano.
ES2136724T3 (es) Emulsion liofilizada, que contiene una sustancia activa.
ES2058977T3 (es) Preparado absorbible por via percutanea a base de eperisona o tolperisona.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
ES2157221T3 (es) Composiciones metaloporfirinicas.
ES2038064B1 (es) Instalacion portatil de vacunacion aviar.